Cabaletta Bio is trading up 6.08% at $2.00 on October 2, 2026, in line with a broader risk-on session. - U.S. stocks rallied after September payrolls came in below expectations, easing concerns about another near-term Federal Reserve rate hike. - The S&P 500, Nasdaq Composite, and Dow were all higher. No clear company-specific catalyst surfaced in the search, making broader market sentiment the likeliest context for the gain.